Journal
CELLULAR SIGNALLING
Volume 20, Issue 12, Pages 2302-2308Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.cellsig.2008.08.019
Keywords
Bone homeostasis; Osteoclasts; RANKL; Osteoclastogenesis; c-Jun; NFATc1
Categories
Funding
- Korea Science and Engineering Foundation (KOSEF)
- Korea government [ROA-2008-000-20001-0]
- KOSEF [M1-0641-35-0002, RO1-2007-000-20141-0]
- NCRC [R15-2006-020]
- Ewha Womans University
- BK21
Ask authors/readers for more resources
Osteoclasts are hematopoietic lineage derived-multinucleated cells that resorb bone. Their activity in balance with that of osteoblast is essential for bone homeostasis. Receptor activator of NF-kappa B ligand (RANKL) is known as an essential cytokine for the osteoclastogenesis, and c-Jun signaling in cooperation with NFAT family is crucial for RANKL-regulated osteoclastogenesis. We show here that schlafen2 (Slfin2), a member of a new family of growth regulatory genes involved in thymocyte development, is critical for osteoclastogenesis. RANKL selectively induces Slfn2 expression in osteoclast precursors via Rac1 signaling pathway. Targeted inhibition of Slfn2 by small interfering RNAs (siRNAs) markedly inhibits the formation of osteoclasts by diminishing the activation of c-Jun and the expression of c-Jun and NFATc1. In contrast, the overexpression of Slfn2 markedly increased phosphorylation and transactivation of c-Jun by RANKL. Together, these results indicate that Slfn2 has an essential role in osteoclastogenesis, functioning upstream of c-Jun and NFATc1. (c) 2008 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available